MM2 Group's Sugarest(tm) Featured on Fox Network's 'Good Day New York' Program

MM2 Group's Sugarest(tm) Featured on Fox Network's 'Good Day New York' Program

Diet Product Provides "Instant Will Power" to Avoid Sugar and Sweets

LIVINGSTON, N.J., March 8 /PRNewswire-FirstCall/ -- MM2 Group, Inc. (BULLETIN BOARD: MMGP) announced today that Sugarest(tm), the diet gum created by its wholly-owned subsidiary, Genotec Nutritionals, Inc., was featured in a story broadcast on the Fox Network's "Good Morning New York" program in New York City. In addition to broadcasting a news segment about the product, Sugarest(tm) was used live in the studio by the program anchors. Their reaction, caught live, is typical for users of the product.

The Sugarest(tm) feature can be seen on the Fox website at http://www.myfoxny.com/myfox/pages/Home/Detail;jsessionid=9120D00D79AC832DB743 FE6650FBEFEC?contentId=2523890&version=1&locale=EN- US&layoutCode=VSTY&pageId=1.1.1

Sugarest(tm) is a minty tablet which dissolves in your mouth and temporarily blocks and neutralizes the sweet-taste receptors of your taste buds. Simply place a tablet in your mouth for 2 minutes, and sugary foods and sweets lose their taste and appeal, giving a dieter the "instant willpower" they need to keep to their diet. The effect lasts for 20-30 minutes, long enough for a dieter to defeat their sugar cravings and lose their desire for sweet but fattening foods. Additional information may be found on the Sugarest(tm) website at www.sugarest.com.

Mark Meller, CEO of MM2 Group, said, "Media coverage of Sugarest(tm) has been unprecedented. We are already manufacturing additional product to keep up with the demand."

George Kontonotas, President of Genotec Nutritionals, stated, "The response to Sugarest(tm) has been so fantastic, we've had to re-design our website to handle our order flow. We expect to announce the launch of this new, robust and informative website in the next few days. We are very excited about the future for the product and for the Company."

About MM2 Group, Inc.

MM2 Group is involved in the acquisition and build-out of dietary supplement and nutraceutical companies. The company's growth strategy is to acquire firms in this extensive and expanding but highly fragmented segment as it seeks to create substantial value for shareholders. For more information, contact MM2 Group CEO Mark Meller at (732) 290-0019 or by e-mail at meller@mm2group.net or Jerry Mahoney at jerrym@mm2group.net.

This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding among other things our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated," and "potential," among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to MM2 Group, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.

Source: MM2 Group, Inc.

CONTACT: Mark Meller, CEO, +1-732-290-0019, meller@mm2group.net, or
Jerry Mahoney, jerrym@mm2group.net, both of MM2 Group

Web site: http://www.mm2group.net/

-------
Profile: intent